{
    "title": "Auris Medical shares plunge as deafness drug trial scrapped",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5124773/UPDATE-1-Auris-shares-tank-plans-end-key-trial-deafness-drug.html",
    "date": "2017-11-28",
    "keywords": [
        "drug",
        "study",
        "hearing",
        "trial",
        "divya",
        "grover",
        "latestage",
        "treatment",
        "deafness",
        "developer",
        "loss",
        "mg",
        "dose",
        "improvement",
        "meyer",
        "assent",
        "year",
        "tinnitus",
        "record",
        "low",
        "tuesday",
        "balance",
        "goal",
        "failure",
        "hope",
        "news",
        "subgroup",
        "need",
        "executive",
        "thomas",
        "placebo",
        "am111",
        "ability",
        "population",
        "auris",
        "company",
        "health",
        "dosage",
        "sense",
        "design",
        "half",
        "variety",
        "ringing",
        "ear",
        "quarter",
        "otonomy",
        "inc",
        "monday",
        "commercialization",
        "infection",
        "otiprio",
        "shift",
        "focus",
        "pipeline",
        "submission",
        "marketing",
        "application",
        "market",
        "cap",
        "value",
        "percent",
        "morning",
        "trading",
        "reporting",
        "bengaluru",
        "editing",
        "dcouto"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}